🔴 Neuronetics is trading 8.6% down

Neuronetics is trading at $1.97, down 8.60%, with no clear company-specific announcement or event identified to explain the November 9 decline.

• The November 4 report showed revenue of $42.0 million, up 12.5% year over year, and adjusted EBITDA of $1.9 million; it does not establish the reason for this session’s drop.
• B. Riley reiterated a Buy rating and raised its target to $6.00 on November 6, not a negative catalyst.
• Major indices are reported higher, so the decline does not appear to track the supplied broad-market direction.